Propionic Acid for Multiple Sclerosis: Safety and Benefits

Clinical trial NCT07595081 · COMPLETED

Trial details

NCT number: NCT07595081
Sponsor: Salzburger Landeskliniken
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2024-08-01
Primary completion: 2025-05-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.